HCPCS Code C1725: Catheter, Transluminal Angioplasty, Non-Laser

Key Takeaways

HCPCS Code C1725 describes a catheter, transluminal angioplasty, non-laser, used to dilate stenotic arteries and veins.

C1725 falls under Temporary Hospital OPPS C-codes (range C1724-C1736), billed on UB-04 for outpatient hospital and ASC settings.

UnitedHealthcare excludes C1725 from reimbursement under implant revenue codes; verify payer policy before submitting.

Pabau’s claims management software helps cardiovascular and vascular practices track HCPCS device codes, document procedures accurately, and reduce claim errors.

HCPCS Code C1725: Definition and Official Description

Cardiovascular billing teams routinely see denials on device codes when documentation fails to match what the payer expects. HCPCS Code C1725 is one of those codes where the gap between clinical intent and billing execution frequently causes problems. Getting it right requires understanding both the device category and the OPPS payment framework that governs it. Pabau’s claims management workflows are built to support exactly this kind of device-specific billing precision.

The official CMS long description for HCPCS Code C1725 is: Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability). The short descriptor used in claims processing is “Cath, translumin non-laser.” According to the CMS HCPCS Level II overview, C1725 is classified under Temporary Hospital OPPS C-codes, maintained by CMS for outpatient prospective payment purposes. CMS’s own device category definitions confirm the clinical purpose: these catheters are designed to dilate stenotic blood vessels, including both arteries and veins.

The code sits within the Catheters for Multiple Applications range, spanning C1724 through C1736. While balloon angioplasty is the most common clinical context, the code’s scope extends to any transluminal, non-laser mechanism used to open narrowed vessels. Infusion or perfusion capability and imaging guidance integration may be included without requiring a different code, as these features fall within the descriptor’s explicit parenthetical.

When to Use HCPCS Code C1725: Procedures and Clinical Context

C1725 applies when a transluminal angioplasty catheter is used in a non-laser procedure to treat vascular stenosis. The most common procedures driving this code include peripheral balloon angioplasty, coronary angioplasty without stent deployment, and certain infusion-guided vessel dilation procedures. It does not apply when a laser-based mechanism is used, as a separate device category governs laser angioplasty catheters.

Shockwave Medical’s peripheral intravascular lithotripsy (IVL) reimbursement guidance identifies C1725 as one of two reporting options for the Shockwave Peripheral IVL catheter, alongside C1889 (implantable/insertable device, not otherwise classified). When the IVL device meets the C1725 descriptor, reporting C1725 is the preferred approach, as C1889 is a catch-all code that may receive additional payer scrutiny. Coders should verify payer policy before selecting between these two options.

Coding professionals should also review the related procedure codes that may be reported alongside C1725 for complete claim capture, particularly CPT codes for the vascular intervention itself.

Medicare and OPPS Coverage for HCPCS Code C1725

CMS designates C1725 as a Temporary Hospital OPPS C-code under the Hospital Outpatient Prospective Payment System. Special coverage instructions apply to this code, meaning payers may have facility-specific or policy-specific rules that go beyond the standard OPPS payment logic. Billing staff should confirm current Ambulatory Payment Classification (APC) assignments directly with CMS or their Medicare Administrative Contractor before submission.

C-codes in the OPPS framework may be eligible for pass-through payment status, which allows separate, cost-based reimbursement for designated new devices during a transitional period. Pass-through status is not permanent and is reviewed annually through the CMS rule-making process. If C1725 held pass-through status in a prior year, that status may have expired or changed. Practices should consult the current OPPS Addendum B to confirm the payment indicator for the relevant fiscal year. Understanding the OPPS device category framework is essential for accurate billing workflow guidance across all outpatient device codes.

Commercial Payer Policy: UnitedHealthcare

UnitedHealthcare’s Commercial Reimbursement Policy (UB-04) explicitly lists C1725 among HCPCS codes that do not meet the FDA definition of an implant. As a result, claims that append an implant revenue code to C1725 will not be reimbursed under UHC’s device/implant policy. This is a common denial trigger for facilities that route all C-codes through implant revenue code pathways without first verifying the payer’s classification criteria.

Other commercial payers may have different interpretations. Always verify coverage and revenue code assignment against each payer’s current policy document before claim submission.

Documentation Requirements for HCPCS Code C1725

Accurate documentation is the first line of defense against C1725 claim denials. Operative or procedure notes must establish that a non-laser transluminal angioplasty catheter was used during the reported service. Documentation that omits the device type or describes a laser-based mechanism creates a mismatch with the C1725 descriptor, which leads to denial or audit exposure. Maintaining HIPAA-compliant documentation standards across all device codes is equally critical for audit preparedness.

The procedure record should also capture any guidance, infusion, or perfusion capabilities integrated into the catheter system, since the C1725 descriptor explicitly includes these features. If those capabilities were used but not documented, the claim may still pass, but the record creates a weaker defense in the event of a post-payment audit.

• Operative/procedure note: Confirm non-laser transluminal angioplasty catheter use and target vessel(s)
• Device label or invoice: Identify the specific catheter model and manufacturer for charge master reconciliation
• Revenue code: Assign per payer-specific policy (not automatically implant revenue code for UHC)
• Physician order: Support medical necessity for the vascular intervention
• Diagnosis code pairing: Link to the stenosis, atherosclerosis, or other vascular diagnosis driving the procedure

Modifiers for HCPCS Code C1725

C1725 is a device/supply code, not a professional service code. Standard evaluation and management modifiers (25, 57) do not apply. Modifiers relevant to outpatient hospital billing in the OPPS context include site-of-service designators and those affecting payment for bilateral or multiple procedures. Practices billing from ambulatory surgical centers should confirm ASC-specific modifier requirements with their payer, as ASC payment rates differ from hospital outpatient rates for the same code.

When C1725 is reported alongside the vascular intervention CPT code, ensure the device code appears on its own line on the UB-04 with the appropriate revenue code. Do not bundle device codes into the procedure charge without verifying that unbundled device reporting is required or permitted by the payer. The National Correct Coding Initiative (NCCI) edits apply to the CPT procedure codes billed on the same claim, so review NCCI pair edits for the associated vascular CPT before finalizing the claim. Reviewing resources like the AAPC Codify HCPCS lookup can help confirm modifier and bundling requirements in real time.

Reduce HCPCS Device Code Denials with Pabau

Pabau's claims management tools help cardiovascular and vascular practices build accurate charge master entries, track device code requirements, and document procedures in a way that supports clean claim submission.

Book a demo

Claim Submission for HCPCS Code C1725: Outpatient Hospital vs. ASC

C1725 is billed on the UB-04 claim form in outpatient hospital and ambulatory surgical center settings. It is not a physician fee schedule code and does not appear on the CMS-1500. The revenue code assigned to C1725 should reflect your facility’s charge master mapping and be consistent with payer-specific requirements, particularly around implant versus supply coding distinctions.

For outpatient hospital claims, the OPPS APC assignment drives payment, and the device cost may be packaged into the procedure APC rather than paid separately. ASC reimbursement follows a distinct fee schedule, and device-intensive procedures may qualify for additional device payment if the implantable device cost exceeds a threshold defined in the ASC payment rules. Since C1725 is not classified as an implant by at least one major commercial payer, the applicable rules differ by setting. Always verify the current payment status using the PGM Billing HCPCS lookup tool or CMS’s official OPPS payment files.

Practices managing multiple service lines benefit from standardized billing workflows that flag device code claims for secondary review. The best EMR and practice management platforms support charge capture workflows that reduce the risk of device codes being omitted or miscoded at the point of service.

Common Denials and Billing Errors for HCPCS Code C1725

The most consistent denial pattern for C1725 involves revenue code misassignment. When facilities route all device codes through implant revenue code pathways without payer-specific verification, UHC and potentially other commercial payers deny the claim outright. The fix is a pre-submission edit that cross-references the code against the payer’s implant exclusion list.

A second common issue involves C1725 versus C1889 selection for peripheral IVL procedures. Without a written coding policy that references the Shockwave Medical reimbursement guidance and current payer instructions, coders default to C1889 as the “safe” catch-all. This leaves potential reimbursement accuracy on the table and may trigger medical necessity review. Documenting the rationale for code selection in the coding policy reduces audit risk and supports appeals if a denial occurs. Practices managing complex cardiovascular documentation workflows can benefit from the billing codes reference resources available for related procedure types.

Expert Picks

Need to streamline device code billing across multiple payers? Claims Management Software helps practices reduce denials and manage HCPCS device codes with built-in payer rule support.

Looking for HCPCS billing workflow guidance? Procedure Codes Billing Reference covers billing workflow best practices applicable across outpatient and ASC settings.

Managing HIPAA-compliant documentation for device-intensive procedures? HIPAA Compliance for Clinic Software outlines documentation standards that support clean claim submission and audit readiness.

Conclusion

HCPCS Code C1725 is a precise device code with specific payer rules that differ meaningfully across Medicare, UnitedHealthcare, and ASC billing contexts. The most preventable failure point is revenue code misassignment, particularly with commercial payers that exclude C1725 from implant reimbursement pathways. Accurate claim submission requires procedure-level documentation, current OPPS payment status verification, and a payer-specific charge master mapping.

Pabau’s claims management tools support cardiovascular and vascular practices in building the kind of structured documentation and billing workflows that keep C-code claims clean from the start. To see how Pabau handles device code billing, book a demo with the team.

Frequently Asked Questions